Business Insider20d
Piper Sandler Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM)
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report), with a price target of $36.00. The company’s shares ...
NBC Washington22d
Why people who aren't diabetic are using wearable glucose monitors
For years, people with diabetes have used continuous glucose ... Once the applicator sticks to the skin, it gets to work and a tiny sensor tracks glucose levels in real time.
Business Insider20d
Stifel Nicolaus Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM)
In a report released today, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report), with a price target of $60.00. The company’s shares ...